Saturday, October 24, 2026Daily EditionIndependent journalism
BeCrypto NewsIndependent digital asset reporting
Sign in Write
BTC $80,267 −1.57%ETH $2,324.04 −3.41%SOL $100.67 −3.45%XRP $1.28 −2.45%BNB $725.87 −2.41%DOGE $0.0766 −3.90%Prices: CoinGecko,
Back
Markets

BeOne Reports 36% Response Rate for Liver Cancer Drug in Phase 1

By John Kim for TokenPost

Image: TokenPost

The result came from 25 evaluable patients given 450 milligrams every three weeks; BeOne plans larger trials by the end of 2026.

Read the full story on TokenPost

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.

Latest in Markets

All Markets stories